AU Patent

AU2020205315A1 — Compositions of obeticholic acid and methods of use

Assigned to Intercept Pharmaceuticals Inc · Expires 2020-08-06 · 6y expired

What this patent protects

The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions. 169

USPTO Abstract

The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions. 169

Drugs covered by this patent

Patent Metadata

Patent number
AU2020205315A1
Jurisdiction
AU
Classification
—
Expires
2020-08-06
Drug substance claim
No
Drug product claim
No
Assignee
Intercept Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.